Although our findings indicate that plasma concentrations of chemokine CCL11 could act as a potential biological marker to differentiate between primary and substance-induced MDD in CUD patients, further clinical research is necessary to confirm the role of inflammatory mediators in dual depression. Here, CCL11 is linked to major depressive disorder.